Clinical Trial Update: Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating multiple-dose intraventricular administration of Rhenium-186 NanoLiposome for leptomeningeal metastasis. The study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leptomeningeal Metastasis

Drugs mentioned

• Rhenium-186 NanoLiposome (Rhenium-186 NanoLiposome)

Snippet

Sponsor: Plus Therapeutics | Conditions: Leptomeningeal Metastasis | Phase 1 | Status: RECRUITING